Newsletter Analysis: Invest in Neuro Event Labs for Epilepsy Care

1. Contents of the Newsletter:

The newsletter introduces an investment opportunity in Neuro Event Labs, a Finnish MedTech company that has developed AI-powered technology to detect and monitor seizures in epilepsy patients. The company's flagship product, Nelli, is a contact-free seizure monitoring solution that uses a camera and microphone to detect and classify motor seizures without the need for patients to wear a device. The newsletter highlights the importance of improving seizure detection and monitoring for the over 65 million people worldwide affected by epilepsy, emphasizing the gap in current healthcare practices that often lead to undetected seizures.

2. Products:

Neuro Event Labs offers Nelli, an AI-powered seizure monitoring solution that is CE-marked in Europe and FDA-cleared for hospital use in the US. Nelli has been used with over 7,000 patients in more than 60 hospitals and has generated approximately €1.2 million in revenue in 2025. The technology is scalable with a B2B SaaS model, working with hospital, EEG, pharma, and home-monitoring partners to expand its reach across Europe and the US.

3. About Invesdor Store (invesdor.nl):

Invesdor is an investment platform that connects investors with innovative companies like Neuro Event Labs. The platform offers investment opportunities in various sectors, including healthcare and technology. Invesdor provides detailed information about the investment type, equity offered, price per share, and maximum issue size for interested investors. With strong healthcare investor backing, Invesdor ensures transparency and support for investors looking to fund promising MedTech ventures like Neuro Event Labs.